Gliclazide: The effects on lipids in type II diabetes

AN investigation into the effects of Gliclazide, a second generation oral hypoglycaemic agent is reported. Triglyceride levels were significantly reduced but this appeared to be a function of the hypoglycaemic effect of the drug rather than a direct effect. No significant change was found in high density lipoprotein or low density lipoprotein cholesterol.